Some effects of a monoamine oxidase inhibitor upon changes produced by centrally administered amines.
In cats treated with subcutaneous or intraperitoneal injections of the monoamine oxidase inhibitor phenylisopropylhydrazine, the effects of 5-hydroxytryptamine injected into the lateral cerebral ventricle were greatly intensified and prolonged; the effects of adrenaline were potentiated to a lesser extent. Those of noradrenaline, dopamine and tryptamine were not intensified and were prolonged to only a slight degree.
D000588:Amines / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D004298:Dopamine; D004837:Epinephrine; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine; D010659:Phenylhydrazines / Q000031:analogs & derivatives; D012701:Serotonin
D000588:Amines; D008996:Monoamine Oxidase Inhibitors; D010659:Phenylhydrazines; C030299:phenylhydrazine; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine
AMINES/pharmacology; MONOAMINE OXIDASE INHIBITORS/pharmacology; PHENYLHYDRAZINE/related compounds